Medical Research and Clinical Trials

Revolutionizing Cell and Gene Therapy: CGTxchange Platform Aims to Resurrect Shelved Innovations

• Medical Research and Clinical Trials

Revolutionizing Cell and Gene Therapy: CGTxchange Platform Aims to Resurrect Shelved Innovations

Jia Lissa May 16, 2026 0

New AI-Powered Marketplace Connects Academics, Investors, and Biotechs to Revitalize Promising but Stalled CGT Programs In a...

Read More Read more about Revolutionizing Cell and Gene Therapy: CGTxchange Platform Aims to Resurrect Shelved Innovations

A Paradigm Shift in Cancer Immunotherapy: Mount Sinai Scientists Unveil "Trojan Horse" Strategy Against Metastatic Disease

• Medical Research and Clinical Trials

A Paradigm Shift in Cancer Immunotherapy: Mount Sinai Scientists Unveil "Trojan Horse" Strategy Against Metastatic Disease

Suro Senen May 15, 2026 0

NEW YORK, NY – January 22, 2024 – In a significant breakthrough that could redefine the battle...

Read More Read more about A Paradigm Shift in Cancer Immunotherapy: Mount Sinai Scientists Unveil "Trojan Horse" Strategy Against Metastatic Disease

REGENXBIO’s Gene Therapy Shows Promising Efficacy in Phase III Trial, Poised for FDA Submission

• Medical Research and Clinical Trials

REGENXBIO’s Gene Therapy Shows Promising Efficacy in Phase III Trial, Poised for FDA Submission

Rifan Muazin May 15, 2026 0

San Francisco, CA – [Insert Date] – REGENXBIO Inc. has announced compelling data from the Phase III...

Read More Read more about REGENXBIO’s Gene Therapy Shows Promising Efficacy in Phase III Trial, Poised for FDA Submission

Groundbreaking Research Rewrites Understanding of Tumour Development in Neurofibromatosis Type 1

• Medical Research and Clinical Trials

Groundbreaking Research Rewrites Understanding of Tumour Development in Neurofibromatosis Type 1

Lina Irawan May 15, 2026 0

London, UK – February 25 – In a significant paradigm shift that challenges decades of conventional wisdom,...

Read More Read more about Groundbreaking Research Rewrites Understanding of Tumour Development in Neurofibromatosis Type 1

Biogen Advances Tau-Targeting Alzheimer’s Therapy Diranersen to Phase III Despite Missing Primary Endpoint in Mid-Stage Trial

• Medical Research and Clinical Trials

Biogen Advances Tau-Targeting Alzheimer’s Therapy Diranersen to Phase III Despite Missing Primary Endpoint in Mid-Stage Trial

Reynand Wu May 15, 2026 0

Boston, MA – [Insert Date] – Biogen is pushing forward with a pivotal Phase III registrational program...

Read More Read more about Biogen Advances Tau-Targeting Alzheimer’s Therapy Diranersen to Phase III Despite Missing Primary Endpoint in Mid-Stage Trial

Unraveling Cancer’s Achilles’ Heel: UMass Chan Scientists Redefine How Drugs Kill BRCA-Mutant Cells, Offering New Hope Against Drug Resistance

• Medical Research and Clinical Trials

Unraveling Cancer’s Achilles’ Heel: UMass Chan Scientists Redefine How Drugs Kill BRCA-Mutant Cells, Offering New Hope Against Drug Resistance

Sagoh May 15, 2026 0

WORCESTER, MA – In a groundbreaking discovery that could fundamentally alter the landscape of cancer treatment, scientists...

Read More Read more about Unraveling Cancer’s Achilles’ Heel: UMass Chan Scientists Redefine How Drugs Kill BRCA-Mutant Cells, Offering New Hope Against Drug Resistance

Labour’s Leadership Under Scrutiny as Health Secretary Resigns Amidst Election Blow

• Medical Research and Clinical Trials

Labour’s Leadership Under Scrutiny as Health Secretary Resigns Amidst Election Blow

Muslim May 15, 2026 0

London, UK – The Labour Party is facing a period of significant internal turmoil following the resignation...

Read More Read more about Labour’s Leadership Under Scrutiny as Health Secretary Resigns Amidst Election Blow

A New Dawn in Immunotherapy: IgE Antibodies Reprogram Tumours, Offering Hope for Resistant Cancers

• Medical Research and Clinical Trials

A New Dawn in Immunotherapy: IgE Antibodies Reprogram Tumours, Offering Hope for Resistant Cancers

Siti Muinah May 15, 2026 0

London, UK – In a significant stride forward in the battle against cancer, scientists at King’s College...

Read More Read more about A New Dawn in Immunotherapy: IgE Antibodies Reprogram Tumours, Offering Hope for Resistant Cancers

Survodutide Shows Promising Dual Action in Preclinical Models, Offering Hope for Diabetic Kidney Disease and Metabolic Disorders

• Medical Research and Clinical Trials

Survodutide Shows Promising Dual Action in Preclinical Models, Offering Hope for Diabetic Kidney Disease and Metabolic Disorders

Asep Darmawan May 15, 2026 0

A groundbreaking preclinical study presented at the European Congress on Obesity (ECO) has unveiled the potential of...

Read More Read more about Survodutide Shows Promising Dual Action in Preclinical Models, Offering Hope for Diabetic Kidney Disease and Metabolic Disorders

Unlocking the Colorectal Cancer Paradox: Landmark Study Reveals Dual Nature of Immune Cells, Paving Way for Precision Immunotherapy

• Medical Research and Clinical Trials

Unlocking the Colorectal Cancer Paradox: Landmark Study Reveals Dual Nature of Immune Cells, Paving Way for Precision Immunotherapy

Azzam Bilal Chamdy May 14, 2026 0

NEW YORK, NY – For decades, the role of regulatory T (Treg) cells in cancer has been...

Read More Read more about Unlocking the Colorectal Cancer Paradox: Landmark Study Reveals Dual Nature of Immune Cells, Paving Way for Precision Immunotherapy